-
admin
Posts
WeShop Helps Pet Lovers Turn Everyday Pet Spending into Ownership with Chewy and PetSmart
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) — WeShop Holdings Limited (“WeShop” or the “Company”) (NASDAQ: WSHP), the world’s first community-owned social commerce platform, allows...
ODDITY Tech Reports Record Full Year 2025 Results
Fourth quarter net revenue of $153 million, up 24% year-over-year Fourth quarter adjusted EBITDA of $13 million Fourth quarter net income of $6 million and...
O-I to Present at BofA Securities 2026 Global Agriculture and Materials Conference
Maintaining Full-Year 2026 Guidance, But Seeing Additional Earnings Pressure in 1Q26 PERRYSBURG, Ohio, Feb. 25, 2026 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE ...
Loblaw Reports Adjusted Diluted Net Earnings Per Common Share Growth of 10.9% in the Fourth Quarter on a 12-Week Comparable Basis
BRAMPTON, Ontario, Feb. 25, 2026 (GLOBE NEWSWIRE) — Loblaw Companies Limited (TSX: L) (“Loblaw” or the “Company”) announced today its unaudited financial results for the...
Target Corp Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Incubators, ICT, Technology Initiatives, Partnerships, Investments, Acquisitions, Network Map
Target’s market opportunities lie in its diverse product offerings, exclusive brand partnerships, and strong digital transformation and innovation strategies. Its focus on technology initiatives, including...
Celldex Completes Enrollment in Global Phase 3 Studies (EMBARQ-CSU1 and EMBARQ-CSU2) of Barzolvolimab in Chronic Spontaneous Urticaria
Enrollment completed six months ahead of guidance, driven by significant unmet need for better treatments in CSU Topline data expected Q4 2026 BLA submission planned...
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively Reported total operating expenses of...
Upstream Bio to Participate in Upcoming March Investor Conferences
WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus...
Aquestive Therapeutics to Participate in Upcoming March Investor Conferences
WARREN, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement...
EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026
WATERTOWN, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) — EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives...
